Skip to main content
Vivian Lee, MD, Ophthalmology, Philadelphia, PA

VivianLeeMD

Ophthalmology Philadelphia, PA

Anterior Segment Related, Ocular Oncology

Assistant Professor

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    51 N 39th St
    Philadelphia, PA 19104
    Phone+1 215-662-8100

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Ocular Oncology/Ophthalmic Pathology, 2011 - 2012
  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2008 - 2011
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2007 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2007

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2008 - 2026
  • WI State Medical License
    WI State Medical License 2011 - 2013
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • Highmark Health Engages Verily to Reinvent the Healthcare Experience for Highmark Health Customers and Clinicians
    Highmark Health Engages Verily to Reinvent the Healthcare Experience for Highmark Health Customers and CliniciansMarch 2nd, 2021
  • Study Reveals Possible Solution to Elevated Cancer Risk from Important Anti-Infection Drug
    Study Reveals Possible Solution to Elevated Cancer Risk from Important Anti-Infection DrugNovember 5th, 2019

Professional Memberships